Diffuse follicle center lymphoma, lymph nodes of multiple sites
ICD-10 C82.58 is a billable code used to indicate a diagnosis of diffuse follicle center lymphoma, lymph nodes of multiple sites.
Diffuse follicle center lymphoma (DFCL) is a subtype of non-Hodgkin lymphoma characterized by the proliferation of neoplastic B-cells in the follicle center of lymphoid tissue. This condition typically presents with enlarged lymph nodes in multiple anatomical sites, which may include cervical, axillary, and inguinal regions. Patients may exhibit B-symptoms such as fever, night sweats, and unexplained weight loss, indicating systemic involvement. The diagnosis is confirmed through histopathological examination of lymph node biopsies, which reveal a diffuse pattern of follicle center cell proliferation. Staging of DFCL is crucial for determining prognosis and treatment strategies, often utilizing the Ann Arbor staging system. Treatment protocols may include chemotherapy regimens, monoclonal antibody therapy, and in some cases, stem cell transplantation, depending on the stage and patient’s overall health. Regular follow-up and monitoring for treatment response and potential complications are essential components of patient management.
Detailed pathology reports, staging information, and treatment plans.
Initial diagnosis, treatment planning, and follow-up care for lymphoma patients.
Ensure accurate coding of treatment modalities and response assessments.
Comprehensive biopsy reports and histological findings.
Biopsy interpretation and staging of lymphomas.
Clear documentation of histological subtype is critical for accurate coding.
Used for monitoring blood counts during treatment.
Document the reason for CBC and any abnormalities noted.
Hematology specialists should ensure accurate interpretation of results.
Common symptoms include swollen lymph nodes, fever, night sweats, and unexplained weight loss. Patients may also experience fatigue and other systemic symptoms.
